$AMRX

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$AMRXSEC Form 4bearish

Shah Nikita · Executive Vice President at Amneal Pharmaceuticals, Inc. · 3h agono track record yet

Sold 146,403 @ $17.51 avg · $2,563,517 · 2026-08-12

Form 4: Shah Nikita sold AMRX

Shah Nikita (Executive Vice President at Amneal Pharmaceuticals, Inc.) reported an open-market sale of 146,403 shares of AMRX at an average $17.51, roughly $2,563,517, in a Form 4 filed 2026-08-13.

View filing on SEC.gov →

$AMRXSEC Form 4bearish

Daly Jason B. · EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc. · 3h agono track record yet

Sold 216,613 @ $17.41 avg · $3,771,050 · 2026-08-11

Form 4: Daly Jason B. sold AMRX

Daly Jason B. (EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc.) reported an open-market sale of 216,613 shares of AMRX at an average $17.41, roughly $3,771,050, in a Form 4 filed 2026-08-13.

View filing on SEC.gov →

End of results.